Highlights of ASH in the Mediterranean, Middle East, and North Africa
Save the Date!
Join the world's leading hematology experts at Highlights of ASH in the Mediterranean, Middle East, and North Africa, a two-day program that highlights the most influential research presented at the latest ASH annual meeting, the premier event in malignant and non-malignant hematology.
Registration for 2025 Highlights of ASH in the Mediterranean, Middle East, and North Africa is now open!
April 4-5, 2025
Hyatt Regency Casablanca, Casablanca, Morocco
About Highlights of ASH in the Mediterranean, Middle East, and North Africa
By attending Highlights of ASH, you will get a comprehensive review of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care.
Through participation in this meeting, you will be able to:
Access a program curated from highlights of the ASH annual meeting which covers the latest and most influential topics in hematology.
Engage in interactive panel discussions with speakers and attend small group lunch sessions with experts in the field.
This meeting has been designed to be a rewarding educational event for hematologists, oncologists, fellows and trainees, allied health professionals, and hematopathologists.
Program Co-Host
ASH is proud to co-host this meeting with the Société Marocaine d'Hématologie.
Program Co-Chairs
The Program Co-Chairs for the Highlights of ASH in the Mediterranean, Middle East, and North Africa are:
- Société Marocaine d'Hématologie Program Co-Chairs
- Dr. M'hamed Harif
- Dr. Nisrine Khoubila
- American Society of Hematology Program Co-Chairs
- Dr. Jorge Cortes
- Dr. Kevin Kuo
Program Schedule
8:00 a.m. | Registration and Exhibits Open |
8:45 a.m. | Welcome & Introduction |
9:00 a.m. | Highlights in Aggressive Lymphoma Asma Quessar, MD University Hospital Cheikh Zaid Casablanca, Morocco |
9:30 a.m. |
Highlights in Indolent Lymphoma including Chronic Lymphocytic Leukemia |
10:00 a.m. | From Theory to Practice: Lymphoma Case Discussions Paolo Strati, MD MD Anderson Cancer Center Houston, TX Abdallah Madani, MD Ibn Rochd University Hospital Casablanca, Morocco |
10:30 a.m. | Panel Discussion |
11:00 a.m. | Coffee Break in the Exhibit Hall |
11:30 a.m. | Supportive Care Topics in Hematology Alexis A. Thompson, MD, MPH Children’s Hospital of Philadelphia Philadelphia, PA |
12:00 p.m. | Questions and Answers with Dr. Alexis Thompson |
12:15 p.m. | Lunch in the Exhibit Hall |
1:30 p.m. | Special Education Session: Challenges and Opportunities in Bringing CAR-T Cell Therapy to Africa Michael Russell Bishop, MD University of Chicago Chicago, IL Mhamed Harif, MD Medical School of Casablanca Casablanca, Morocco Syed Osman Ahmed, MD King Faisal Specialist Hospital and Research Center Riyadh, Saudi Arabia |
2:30 p.m. | Panel Discussion |
3:00 p.m. | Coffee Break in the Exhibit Hall |
3:30 p.m. | Thrombosis Joseph Shatzel, MD Oregon Health & Science University Portland, OR |
4:00 p.m. | Bleeding and Platelet Disorders Shelley E. Crary, MD University of Arkansas Medical School Little Rock, AK |
4:30 p.m. | Hemoglobinopathies including Sickle Cell Disease and Thalassemia Kevin Kuo, MD, MSc University of Toronto Toronto, Canada |
5:00 p.m. | Panel Discussion |
5:30 p.m. | Highlights of ASH® Day 1 Program Adjournment |
8:00 a.m. | Registration and Exhibits Open |
8:45 a.m. | Welcome & Introduction |
9:00 a.m. | Acute Myeloid Leukemia Thomas Cluzeau, MD, PhD Centre Hospitalier Universitaire de Nice Nice, France |
9:30 a.m. | Acute Lymphoblastic Leukemia Shira Dinner, MD Northwestern University Chicago, IL |
10:00 a.m. | Panel Discussion |
10:30 a.m. | Coffee Break in the Exhibit Hall |
11:00 a.m. | Myelodysplastic Syndromes Rami Komrokji, MD Moffitt Cancer Center Tampa, FL |
11:30 a.m. | Myeloproliferative Neoplasms Jorge Cortes, MD Augusta University Augusta, GA |
12:00 p.m. | Panel Discussion |
12:30 p.m. | Lunch with the Experts (Ticketed) Lunch in the Exhibit Hall (All Attendees) |
1:30 p.m. | Multiple Myeloma Michaela Liedtke, MD Stanford Medicine Stanford, CA |
2:00 p.m. | Management and Toxicity of Bi-Specifics Luciano Costa, MD University of Alabama Birmingham, AL |
2:30 p.m. | Panel Discussion |
3:00 p.m. | Coffee Break in the Exhibit Hall |
3:30 p.m. | Cellular Therapeutics including Transplant and Gene Therapy Josu de la Fuente, PhD Imperial College London London, UK |
4:00 p.m. | Transfusion Medicine Katerina Pavenski, MD University of Toronto Toronto, Canada |
4:30 p.m. | Panel Discussion |
5:00 p.m. | Highlights of ASH® Adjournment |